Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities

Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities

US Patent 9643961 · Granted May 9, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds active towards nuclear receptors2025
KRas inhibitors2025
Compounds active towards nuclear receptors2023
Mutant IDH1 inhibitors2020
Quinuclidine derivatives and medicinal compositions containing the same2020
Combinations comprising MABA compounds and corticosteroids2019
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2019
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2019
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2019
Amino-substituted heterocyclic derivatives as sodium channel inhibitors2019
Aminoindazole derivatives as sodium channel inhibitors2019
Quinuclidine derivatives and medicinal compositions containing the same2018